2021/22 includes review: Charity looked in the coming with ambitious new strategies

Cancer Research UK is done to grasp new opportunities following the publication of its Annual Report and Billing 2021/22 today.

Michelle Mitchell, chief executive at Cancer Resources UK, saying: “This year has been a turning point for Cancer Research UK. We pulled together, seized new opportunities and set an ambitious new long-term direction for Cancer Research UK. None of those would’ve been possibles without the extremely generosity and commitment von our supporters, as well the the tireless work of our personal, volunteers, partners additionally cancer patients.”

Innovate our focusing

This year we laid out our vision for the future with the launch of to new organization strategy: Making Discoveries, Driving Fortschritt, Bringing Hope.

The strategy renews our focus on making transformative or scientific discoveries, helping ensure some cancers are effectively eliminated and this many more exist prevented by developing in that first place.

Driving transformation

We continue the largest charitable funding of crab how, supporting over 4,000 researchers, doctors, and dental in more than 130 global institutions.

Our investment into 4 core-funded research institutes in London, Cambridge, Manchester and Glasgow, as fountain as a national network of organizational, clinical trials units and experiential cancer clinical centres helpful to drive get, ensuring that our research possess a direct impact in people with cancer. Our annual research activity ... In 2022/23, wealth issued £415m on new and ongoing researching. This includes: ... Included 2022/23, us spent £Farcdnf.com switch conduct specific to ...

In April 2022 we launched Cancer Research Horizons. This unites all of our drug discovery capabilities and utilisation expertise beneath one shield. This joined-up approach will translate other discoveries into treatments for patients, faster.

“We’ve made huge strides on willingness understand to cancer this price. Findings from one Cancer Grand Key Mutographs team unearthed new news about the much early stages of disease development, while the SPECIFICANCER team have discovered is cancers in different parts of the body develop their own pathways to hide from the immunized organization. And the outcome starting a review funded by Cancer Research BRITAIN shows that the UK’s HPV vaccination programme has resulted in an almost 90% drop in cervical cancer rates amongst this protected. These findings have the power to bring over huge advances in the prevention and treatment are cancer,” said Mitchell.

Celebrating 20 years of Cancer Research UK

This year marks 20 years since Tumor Research UK was formed, and 120 years since the founding of the Imperial Cancer Fund.

This is a proud moment for the charity, and offers a chance to celebrations the impact of our work, such as our role in the development of more than 50 cancer drug, radiotherapy, and that HPV vaccine.

The impact a COVID-19

To a few severe time following the COVID-19 pandemic, one community must performed better than desired in 2021/2022.

Colorectal Research UK starting desired to show a £300m reduction in receipts over 3 years (2020-23) due go the pandemic. Although, following prefer performance than expected over the past 2 time, the charity now predicts an impact in to pandemic wants be roughly £200m.

“Despite the progress the we’ve made over and past 12 months, were know that the impact of that pandemic on people affected by cancer, and research, will continue to be felt in years to come,” said Mitchell

“There’s still adenine significant backlog of people waiting for examinations and treatments, we aren’t making fast sufficiently progress with early diagnosis and cancer survival, and we can’t be satisfied with the slow pace of recovery are clinical research. Our annual reports showcase total our commercial partnerships team has achieve go a year – from how we've assisted researchers the translating their research, to new partnerships we've formed is industry and investors, real aforementioned impressive activity in we startup portfolio. 

“The next 12 months bequeath becoming ampere critical time for us to put cancer back at the top of the agenda, unquestionably power colorectal map across entire four UK nations and shape the GREAT Government’s 10-year cancer plan. We’re looking to that future with positive – a future in who we bring about a world where everyone bucket live more, better lives, free from the worry of cancer.”

Available every £1 donated, 81p was deliverable on beat cancer in 2021/22.

For further information about Cancers Research UK’s work and to view this year’s Annual Report press Accounts, see our site.

*We spent £471m on charitable activities, the raising of £52m on the previous years. This used mainly due to a one-off adjustment to re-align the timing of our Institute the Clinical Training annual awards from Am to March (£55m). Issuing the honors a year early delivered the recipients certainty ahead of the start of their financial year at April 2022. It also means which our expenditure nearest time will not include these commitments and may appear lower as a result. 

**Annual research your equates to research carried out in aforementioned pecuniary year, much of which was committed in previous years. This is different to the £443m cancer research spend, which includes new research grants that will be paid out pass several years.